Navigation Links
Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
Date:12/7/2010

is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted the AZ-004 NDA in December 2009.  In October 2010, the Company received a CRL from the FDA, regarding its NDA for AZ-004.  A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form.  The Company is currently evaluating the FDA's comments in the CRL and has scheduled a meeting with the FDA in December 2010 to discuss the CRL.

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development and safety of the Company's product candidates and technologies.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Se
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Market Research Report on Global and Chinese ... and in-depth market survey on Global and ... firstly reviews the basic information of X-Ray Crystallography ... The report then explores global and China,s top ... specification, capacity, Production value, and market share etc. ...
(Date:8/29/2014)... 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the ... turnkey support services for the lawfully organized cannabis ... and approved the Company,s name and symbol change ... will be known as Chuma Holdings, Inc. ... a merger with the Company,s wholly-owned subsidiary, Chuma ...
(Date:8/29/2014)... HILL, N.C. , Aug. 29, 2014 ... Leaders (KOLs) can be the difference between a product,s ... to effectively map and stratify KOL targets – and ... build the type of strong relationships upon which successful ... research, savvy pharma companies have identified internal inconsistencies in ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... , LAUSANNE, Switzerland, October 15 ... low-cost, integrated molecular and,immunodiagnostics based on its proprietary micro-technology ... equity financing round. The,Company raised EUR 10 million ( ... investors. , The deal was ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the ... http://www.cordblood-america.com ) focused on bringing the life ... for families nationwide and internationally, today addressed shareholder questions ... interview of Matthew Schissler, founder and CEO, by analyst ...
Cached Medicine Technology:Biocartis Raises EUR10 Million in Series A Financing Round 2Biocartis Raises EUR10 Million in Series A Financing Round 3Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 2Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 3
(Date:8/30/2014)... 30, 2014 August 28th, 2014: ... in our society and the toll that takes on ... vital that continuing education for physical therapists addresses this ... physical therapists help others, Hands-On Seminars is offering discounts ... , Three learning styles are available to fit the ...
(Date:8/30/2014)... Tulsa, OK (PRWEB) August 30, 2014 LiveStreamingFitness.com, ... as well as other healthy lifestyle resources, is proud to ... affordable nationwide resources for at home fitness solutions by ABC’s ... a recent featured story on ABC’s Good Morning America, “Live ... Now, you can streamline your day by streamlining your workout…to ...
(Date:8/30/2014)... NJ (PRWEB) August 30, 2014 Ms. Meriwether’s ... her. She certainly has an impressive resume to boost. ... Miss USA in 2012. However, she’s also a two ... Grad student. Nana trained for the 2008 Olympics and ... Miss USA website, “This six-foot beauty from Potomac, Maryland is ...
(Date:8/30/2014)... Jake W., 18, is completing his high school degree ... Adventures transition program known as Beyond the Basics. ... actually start on a real career path,” said Jake. “ ... He has six months of sobriety under his belt after ... continue on to the Beyond the Basics transition program notes ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 When a prominent ... ensue, as happened on Wednesday, August 27th, when news began ... on JPMorgan Chase & Co and at least one ... is actually investigating attacks on seven prominent banks , ... may be affected, and the buzz quickly goes viral. ...
Breaking Medicine News(10 mins):Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:LiveStreamingFitness.com is New Trend In Fitness 2Health News:NJ Top Dentists Announces Cover Model for the Healthy Living: Top Dentists Issue 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5
... 4 (HealthDay News) -- Rates of head and neck cancer ... without any known risk factors. Now, a study suggests that ... of precancerous cells in the mouth. Previous research ... the lungs are exposed to smoke. This may lead to ...
... study of its kind, a research team led by Michigan ... the most traumatic situations were less likely to suffer health ... surveyed Army troops fighting in Iraq, could have implications for ... events such as death. Training these first-responders to think in ...
... (RA) who are current smokers were less likely to achieve ... inhibitors than those who never smoked. The study by researchers ... the past did not experience a lower response to these ... 2011 issue of Arthritis & Rheumatism , a journal ...
... Amanda Gardner HealthDay Reporter , MONDAY, Jan. 3 ... cancer on the left side of the colon, new research ... right side. The finding contradicts some previous research that ... However, the right-side benefit shown in the new study, published ...
... FOR MODERATE TO SEVERE ASTHMA ... is safe and effective an add-on treatment to corticosteroids for ... Uruguay, Argentina, and Chile performed a meta-analysis on eight trials ... At the end of the steroid reduction phase, patients taking ...
... The rapid growth in use of medical diagnostic imaging, ... radiation exposure in adults and the potential for future cancer ... led by University of Michigan researchers now shows that kids ... routine clinical care, and highlights the importance of initiatives to ...
Cached Medicine News:Health News:Estrogen May Play Role in Rising Rates of Head, Neck Cancer 2Health News:MSU leads first study of resiliency on the battlefield 2Health News:Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 3Health News:News briefs from the January issue of Chest 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 3
For the quantitative in vitro determination of Lactate Dehydrogenase (LD) in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: